Raelipskie Partnership’s iShares Biotechnology ETF IBB Stock Holding History

Raelipskie Partnership’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.13M	Sell	6,675 -2,085	-24%	-$357K	0.48%	44
2025 Q4	$1.48M	Sell	8,760 -1,013	-10%	-$165K	0.62%	37
2025 Q3	$1.41M	Sell	9,773 -2,275	-19%	-$311K	0.61%	38
2025 Q2	$1.52M	Sell	12,048 -975	-7%	-$120K	0.7%	35
2025 Q1	$1.67M	Sell	13,023 -53,120	-80%	-$7.2M	0.86%	29
2024 Q4	$8.74M	Sell	66,143 -1,659	-2%	-$233K	4.34%	7
2024 Q3	$9.87M	Buy	67,802 +5	+0%	+$723	4.81%	7
2024 Q2	$9.31M	Buy	67,797 +425	+0.6%	+$56.7K	4.97%	6
2024 Q1	$9.24M	Buy	67,372 +1,729	+3%	+$236K	5.27%	6
2023 Q4	$8.92M	Buy	+65,643	New	+$8.01M	5.43%	4

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Raelipskie Partnership's IBB Position: Q1 2026 in Review

Raelipskie Partnership reduced its iShares Biotechnology ETF (IBB) stake by 24% in Q1 2026, selling an estimated $357K and leaving 6,675 shares worth $1.13M. The position accounts for 0.48% of the portfolio, ranked #44.

Raelipskie Partnership first reported a position in IBB in Q4 2023 and has held it in 10 quarters since. The position peaked at $9.87M in Q3 2024. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

Raelipskie Partnership held 6,675 shares of iShares Biotechnology ETF worth $1.13M as of Q1 2026.
Raelipskie Partnership sold 2,085 iShares Biotechnology ETF shares in Q1 2026, an estimated $357K.
iShares Biotechnology ETF made up 0.48% of Raelipskie Partnership's portfolio in Q1 2026, its #44 holding.
Raelipskie Partnership first reported a position in iShares Biotechnology ETF in Q4 2023 and has held it in 10 quarters since.
Raelipskie Partnership's iShares Biotechnology ETF position peaked at $9.87M in Q3 2024.
917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Raelipskie Partnership's 13F filing for Q1 2026, filed 29 Apr 2026.